A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant Women

Clinical trial NCT00855335 · COMPLETED

Trial details

NCT number: NCT00855335
Sponsor: Janssen Scientific Affairs, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

HIV HIV Infections Pregnancy

Start date: 2009-04-09
Primary completion: 2016-08-11
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.